13F-HR filed by Exome Asset Management LLC
Exome Asset Management LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 68 holding rows worth $165,144,912.
- Accession
- 0001420506-25-003369
- Filer
- CIK 2011932
- Filed
- 2025-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 68 entries on the cover page, a total value of $165,144,912 stated on the cover page (in dollars after the unit check, H1), rows summing to $165,144,912 with VALUE read as dollars as filed, 13F file number 028-23951. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 131,016 | $8,571,067 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 142,417 | $7,827,238 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 133,087 | $6,912,539 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 443,547 | $6,369,335 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 98,182 | $6,134,411 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 7,852 | $5,991,076 | dollars as filed | |
| NOVABRIDGE BIOSCIENCES | 44975P103 | CMN | 1,439,604 | $5,441,703 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 101,996 | $5,405,788 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 156,072 | $4,535,452 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 28,362 | $4,269,550 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 61,356 | $4,054,404 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 273,661 | $4,022,817 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 94,400 | $3,750,512 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 156,917 | $3,750,316 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 18,100 | $3,675,024 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 104,507 | $3,604,446 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 43,600 | $3,287,004 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 48,445 | $3,274,882 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 18,650 | $3,002,091 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 229,962 | $2,909,019 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 6,358 | $2,843,488 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 173,439 | $2,813,181 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 6,645 | $2,785,650 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 58,579 | $2,781,331 | dollars as filed | |
| VANECK PHARMACEUTICAL ETF | 92189F692 | ETF | 30,000 | $2,710,800 | dollars as filed | call |
| TRAVERE THERAPEUTICS INC | 89422G907 | COM | 110,000 | $2,629,000 | dollars as filed | call |
| IMMUNOVANT INC | 45258J102 | COM | 158,622 | $2,556,987 | dollars as filed | |
| GERON CORP | 374163103 | COM | 1,858,354 | $2,545,945 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 745,305 | $2,377,523 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 9,000 | $2,279,880 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 27,143 | $2,213,512 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 94,235 | $2,142,904 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 88,024 | $2,134,582 | dollars as filed | |
| NOVO-NORDISK A S | 670100905 | CALL | 35,000 | $1,942,150 | dollars as filed | call |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 163,658 | $1,913,162 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 6,000 | $1,875,180 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 117,783 | $1,812,091 | dollars as filed | |
| WAYSTAR HLDG CORP | 946784105 | COM | 46,900 | $1,778,448 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607AD2 | NOTE 1.250% 9/1 | 2,000,000 | $1,764,414 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576UAA4 | BOND | 2,000,000 | $1,633,605 | dollars as filed | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 7,955 | $1,626,320 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 120,644 | $1,447,728 | dollars as filed | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 39,900 | $1,424,031 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 18,600 | $1,380,120 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 22,090 | $1,289,393 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 178,084 | $1,276,862 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 100,036 | $1,271,458 | dollars as filed | |
| LIQUIDIA CORPORATION | 53635D952 | PUT | 53,000 | $1,205,220 | dollars as filed | put |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 451,699 | $1,187,968 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 292,770 | $1,168,152 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 51,960 | $977,368 | dollars as filed | |
| ARCTURUS THERAPEUTICS HLDGS | 03969T959 | COM | 50,000 | $921,500 | dollars as filed | put |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 52,402 | $917,035 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 98,799 | $908,951 | dollars as filed | |
| MBX BIOSCIENCES INC | 55287L951 | PUT | 50,500 | $883,750 | dollars as filed | put |
| COGENT BIOSCIENCES INC | 19240Q901 | CALL | 45,000 | $646,200 | dollars as filed | call |
| CENTESSA PHARMACEUTICALS PLC | 152309950 | PUT | 25,000 | $606,250 | dollars as filed | put |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 13,100 | $536,969 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W907 | CALL | 10,000 | $530,000 | dollars as filed | call |
| MBX BIOSCIENCES INC | 55287L901 | CALL | 30,000 | $525,000 | dollars as filed | call |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 20,000 | $426,800 | dollars as filed | put |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 75,484 | $342,697 | dollars as filed | |
| PRECIGEN INC | 74017N955 | COM | 100,000 | $329,000 | dollars as filed | put |
| KARYOPHARM THERAPEUTICS INC | 48576U955 | COM NEW | 48,100 | $314,574 | dollars as filed | put |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 73,614 | $308,443 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 60,600 | $188,466 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 173,900 | $153,310 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 40,000 | $28,840 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-25-003369 | this filing | 2025-11-14 | acceptance time not in the bulk data set |